Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis - Guidelines vs. reality

Pharmacological Reports

Volumn 64, Issue 2, 2012, Pages 377-385

  Bozentowicz Wikarek, Maria ^a   Kocełak, Piotr ^a   Smertka, Mike ^a   Olszanecka Glinianowicz, Magdalena ^a   Chudek, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Prevention; Statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BEHAVIOR MODIFICATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT COUNSELING; PRACTICE GUIDELINE; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84862219030     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70778-8     Document Type: Article

References (13)

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C Kirby A et al.: Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005, 366, 1267-1278.
2. Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J: Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation, 2001, 104, 3046-3051. (Pubitemid 34014055)
3. Dimitrow PP, Jawień M. Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia. Pharmacol Rep, 2010, 62, 1250-1254.
4. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE et al.: 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol, 2008, 51, 172-209.
5. Knopp RH: Drug treatment of lipid disorders. N Engl J Med, 1999, 341, 498-511.
6. Krysiak R, Okopień B: Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients. Pharmacol Rep, 2011, 63, 95-101.
7. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B et al.: Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee. Circulation, 2006, 114, 82-96. (Pubitemid 44305278)
8. Marz W, Wollschlager H, Klein G, Neiss A, Wehling M: Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial). Am J Cardiol, 1999, 84, 7-13. (Pubitemid 29307633)
9. Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C: LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO. J Manag Care Pharm, 2007, 13, 652-663. (Pubitemid 350065234)
10. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML et al.: High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA, 2005, 294, 2437-2445. (Pubitemid 41627921)
11. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA et al.: Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA, 2011, 305, 2556-2564.
12. Sattar N, Preiss D, Murray H, Welsh P, Buckley B, de Craen A, Seshasai S et al.: Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet, 2010, 375, 735-742.
13. Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D: Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study. Curr Med Res Opin, 2005, 21, 1389-1399. (Pubitemid 41368570)